Certified by Founder Lodge
Digitalis Ventures
United States - New York, NY
INVESTOR
1 Disclosed Funding Rounds $100,000,000
18 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Digitalis Ventures is a venture capital firm that invests in solutions to complex problems in human and animal health. Digitalis partners with entrepreneurs, scientists, and inventors across
Company | Date | Round | Raised |
---|---|---|---|
GRO Biosciences | July, 23 ,2024 | Series B | $60,300,000 |
Matchpoint Therapeutics | October, 17 ,2022 | Series A | $100,000,000 |
Eden Brew | May, 31 ,2022 | Unknown | $5,000,000 |
Judo Bio | October, 08 ,2024 | Seed | $100,000,000 |
Ness | May, 11 ,2022 | Seed | $15,500,000 |
Switch Therapeutics | March, 15 ,2023 | Series A | $52,000,000 |
Alpha-9 Oncology | October, 24 ,2024 | Series C | $175,000,000 |
Companion | April, 13 ,2023 | Unknown | $6,000,000 |
Ascend Gene & Cell Therapies | May, 10 ,2023 | Series A | $132,500,000 |
T-Therapeutics Ltd | November, 16 ,2023 | Series A | $59,707,000 |
Gallant Therapeutics | January, 09 ,2024 | Series A | $15,000,000 |
Ansel Health | January, 24 ,2024 | Unknown | $20,000,000 |
MoeGo | March, 05 ,2024 | Series A | $24,000,000 |
Alterome Therapeutics, Inc | April, 09 ,2024 | Series B | $132,000,000 |
ELEGEN | May, 16 ,2024 | Series B | $35,000,000 |
GRO Biosciences | July, 23 ,2024 | Series B | $60,300,000 |
Judo Bio | October, 08 ,2024 | Seed | $100,000,000 |
Alpha-9 Oncology | October, 24 ,2024 | Series C | $175,000,000 |